Enter to open, tab to navigate, enter to select
Reverse Break-up Fees: Pharmaceutical Sector
Practical Law Legal Update 4-500-6636 (Approx. 2 pages)
Reverse Break-up Fees: Pharmaceutical Sector
by PLC Corporate & Securities
| Published on 04 Nov 2009 • USA (National/Federal) |
An update on the closing of the Merck/Schering-Plough merger and the use of reverse break-up fees to address financing risk.